Diabetes and Heart Disease & Stroke Prevent Programs-Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke | CDC RFA DP18 1817

Opportunity Information: Apply for CDC RFA DP18 1817

The Centers for Disease Control and Prevention (CDC), through the Department of Health and Human Services and the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), released this discretionary funding opportunity as a cooperative agreement to help state and large local health departments design, test, and evaluate new and practical public health approaches for diabetes and cardiovascular disease (heart disease and stroke). The overall aim is to strengthen real-world prevention and management efforts by applying evidence-based strategies in more innovative ways, especially in communities where the burden of high blood pressure, high cholesterol, diabetes, or prediabetes is disproportionately high. The opportunity is framed around not only reducing disease risk and complications, but also identifying and lowering barriers that keep people from accessing prevention and control services.

A central feature of the program is its focus on reach and measurable population impact. Eligible applicants are state governments and local governments (county, city, township) that serve populations of 900,000 or more, because the CDC is prioritizing jurisdictions where interventions can influence large numbers of residents. Smaller local health departments that do not individually meet the population threshold are not excluded outright; they can form a consortium and apply together as a single applicant, as long as their combined service population meets or exceeds 900,000 (using July 2012 U.S. Census estimates). This structure is intended to let regions with multiple smaller jurisdictions coordinate their work at a scale comparable to a large metropolitan or statewide health department.

The NOFO emphasizes work in "high-burden populations," defined in a data-driven way as groups shown to be disproportionately affected by cardiometabolic conditions due to socioeconomic conditions or related factors. In practice, that pushes applicants to use local surveillance, clinical data partnerships, community health assessments, or other credible sources to identify where disease prevalence, risk factors, complications, and access gaps cluster. The expectation is that proposed strategies will be selected and tailored to those populations and settings where inequities are most evident and where a health department has realistic capacity to achieve wide uptake.

Program activities are organized into two distinct but complementary categories. Category A focuses on diabetes, including both diabetes management (supporting better control and reducing complications among people already diagnosed) and prevention strategies aimed specifically at type 2 diabetes (often by addressing prediabetes and modifiable risk factors). Category B focuses on cardiovascular disease (CVD), covering prevention and management strategies related to heart disease and stroke. Applicants can choose to apply for Category A only, Category B only, or both categories in a single application, as long as the application clearly separates and explains each category's proposed work.

Within each category, applicants are expected to pick from a "menu" of strategies, meaning the CDC is not asking jurisdictions to invent programs from scratch, but to implement and adapt proven approaches while also testing novel methods to improve performance, scalability, and equity. The NOFO language highlights innovation in design, testing, and evaluation, suggesting that the CDC wants awardees to go beyond routine program delivery by experimenting with new partnerships, delivery channels, workflow changes, policy or systems approaches, or other methods that help evidence-based interventions penetrate more effectively into high-burden communities. At the same time, applicants are encouraged to prioritize strategies where they have the strongest capacity to deliver, because the goal is not a long list of activities but a focused plan that can produce meaningful reach and impact.

For applicants proposing to work in both Category A and Category B, the CDC sets two important expectations. First, funds should be divided equally between the two categories. Second, the selected diabetes and CVD strategies should be implemented in the same populations and settings so the efforts reinforce one another rather than compete or operate in silos. This reflects a practical public health view that diabetes, hypertension, cholesterol, and related risk factors often overlap in the same communities and even the same individuals, so coordinated interventions can produce stronger outcomes than separate, unaligned programs.

In terms of funding and logistics, this opportunity (Funding Opportunity Number CDC RFA DP18-1817; CFDA 93.435) uses a cooperative agreement model, which typically means the CDC expects active involvement beyond standard grant oversight, such as technical assistance, shared learning, and collaborative evaluation expectations. The award ceiling is listed as $3,000,000, with an expectation of about 15 awards. The original posting date was May 9, 2018, with an original closing date of July 9, 2018, and electronic submissions required by 11:59 p.m. Eastern Time on the deadline date.

• The Department of Health and Human Services, Centers for Disease Control - NCCDPHP in the health sector is offering a public funding opportunity titled "Diabetes and Heart Disease & Stroke Prevent Programs-Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.435.
• This funding opportunity was created on May 09, 2018.
• Applicants must submit their applications by Jul 09, 2018 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
• The number of recipients for this funding is limited to 15 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments.

Apply for CDC RFA DP18 1817

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: